Netherlands· NL-dd0143b8f1db
Ivergalen 3 mg, tabletten
A ivermectin product containing ivermectine, registered in Netherlands by Galenicum Derma S.L.U.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ivermectin is registered in 15 of 19 countries.
Countries holding a registration under ATC P02CF01 (ivermectin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Ivermectin · ATC P02CF01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- IVERMECTINE
- Manufacturer
- Galenicum Derma S.L.U.
- Country
- Netherlands (NL)
- ATC code
- P02CF01
- ATC class
- Ivermectin
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id125826
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
111 interactions on record for ivermectin.
Graded by severity as the source publishes them — 84 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivermectin · interactions on record
111 records
- 84 moderate
- 2 minor
- 25 info
Most severe, free to view
- AprepitantA04AD12moderate
- LonafarnibA16AX20moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ivermectin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIVERMEKTIN ARISTOAristo Pharma GmbH, Berlin
- FranceIVERMECTINE ARROW LAB 3 mg, compriméARROW GENERIQUES
- United StatesivermectinEPIC PHARMA LLC
- PolandIvermectin Medical ValleyMedical Valley Invest AB
- FinlandIvermectin GlenmarkGlenmark Arzneimittel GmbH
- United KingdomIvermectin 3mg tabletsZydus Pharmaceuticals UK Ltd
- SpainIVERCARE 3 MG COMPRIMIDOS EFGIndustrial Farmaceutica Cantabria S.A.
- NorwayIvermectin GlenmarkGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ivergelan, Ivermectin Stada
- Belgium · Cesora, Ivermectin Eg
- Bulgaria · Ивермектин, Скабал
- Cyprus · Scaball, Soolantra
- Czechia · Ivermektin Aristo, Loutol
- Germany · Driponin, Iveraxiro
- Denmark · Ivermectin Medical Valley, Ivermectin Newbury
- Estonia · Ivermectin Orion, Soolantra
- Spain · Ivercare, Ivergalen
- Finland · Ivermectin Glenmark, Ivermectin Medical Valley
- France · Bibovel, Cesora
- United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
- Greece · Scaball, Soolantra
- Hungary · Soolantra
- Ireland · Iverscab, Soolantra
- Iceland · Ivermcetin Stada, Ivermectin Medical Valley
- Italy · Efacti, Ivercare
- Lithuania · Ivermectin Orion, Soolantra
- Luxembourg · Ivermectin Eg, Ivermectin Substipharm
- Latvia · Ivermectin Orion, Ivermectine Orion
- Malta · Soolantra
- Norway · Ivermectin Glenmark, Ivermectin Medical Valley
- Poland · Ivermectin Medical Valley, Ivermectin Orion
- Portugal · Ivergalen, Ivermectina Cantabria
- Romania · Soolantra
- Sweden · Cesora, Efrinter
- Slovakia · Ivermectin Exeltis, Soolantra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e6dc781-5f38-4990-b3ca-b46c7b648dae GET /v1/drugs/4e6dc781-5f38-4990-b3ca-b46c7b648dae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125826_smpc_en.pdf",
"strength": null,
"atc_label": "Ivermectin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125826",
"excipients": [
"BUTYLHYDROXYANISOL (E 320)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD"
],
"substances": [
"IVERMECTINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125826_piluk.pdf",
"authorised_at": "2020/11/18",
"procedure_number": "NL/H/5040/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "125826",
"additional_monitoring": "N"
}See everything about ivermectin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.